Your browser doesn't support javascript.
loading
External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab.
Konecki, Celine; Feliu, Catherine; Cazaubon, Yoann; Giusti, Delphine; Tonye-Libyh, Marcelle; Brixi, Hedia; Cadiot, Guillaume; Biron, Amélie; Djerada, Zoubir.
Afiliación
  • Konecki C; Department of Pharmacology, EA 3801, SFR CAP-Santé, Reims University Hospital, 51 rue Cognacq-Jay, CEDEX, 51095 Reims, France.
  • Feliu C; Department of Pharmacology, EA 3801, SFR CAP-Santé, Reims University Hospital, 51 rue Cognacq-Jay, CEDEX, 51095 Reims, France.
  • Cazaubon Y; Institute Desbrest of Epidemiology and Public Health, INSERM, University Montpellier, 34000 Montpellier, France.
  • Giusti D; Department of Pharmacology, Montpellier University Hospital, Avenue du Doyen Gaston Giraud, 34090 Montpellier, France.
  • Tonye-Libyh M; Department of Immunology, Reims University Hospital, University of Reims Champagne-Ardenne, CEDEX, 51100 Reims, France.
  • Brixi H; Department of Immunology, Reims University Hospital, University of Reims Champagne-Ardenne, CEDEX, 51100 Reims, France.
  • Cadiot G; Department of Hepato-Gastroenterology and Digestive Oncology, Robert Debré Hospital, Reims-Champagne-Ardennes University, CEDEX, 51100 Reims, France.
  • Biron A; Department of Hepato-Gastroenterology and Digestive Oncology, Robert Debré Hospital, Reims-Champagne-Ardennes University, CEDEX, 51100 Reims, France.
  • Djerada Z; Department of Hepato-Gastroenterology and Digestive Oncology, Robert Debré Hospital, Reims-Champagne-Ardennes University, CEDEX, 51100 Reims, France.
Pharmaceutics ; 13(8)2021 Aug 03.
Article en En | MEDLINE | ID: mdl-34452152

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Francia